Company Filing History:
Years Active: 2015-2020
Title: The Innovative Mind of Rune Harald Gaarder
Introduction
Rune Harald Gaarder, based in Oslo, Norway, is a prominent inventor known for his contributions to the field of medical delivery devices. With a portfolio of three patents to his name, Gaarder has been instrumental in advancing the mechanisms for delivering substances safely and effectively.
Latest Patents
Gaarder’s latest patents showcase his innovative approach to delivery devices. The first patent outlines a delivery device designed for delivering a metered amount of a substance through a user-exhaled airflow. This device incorporates a mouthpiece, an outlet for the substance, and a housing that connects both elements, facilitating the movement of air and substance during use. The second patent further develops this concept with a more refined delivery device that operates similarly but features a dispensing unit with a cavity for containing a metered amount of substance and an outlet nozzle. This enhances the accuracy of the delivered substance, driven by the user's exhalation.
Career Highlights
Rune Harald Gaarder works at Optinose AS, a company renowned for its innovative health solutions. His career is marked by a focus on developing devices that improve the efficiency and efficacy of medication delivery systems, contributing significantly to patient care in the medical field.
Collaborations
In his inventive journey, Gaarder collaborates with esteemed colleagues such as Per Gisle Djupesland and Sébastien Lamolle. Together, they push the boundaries of innovation in respiratory delivery systems, enhancing the user experience and improving health outcomes for patients.
Conclusion
Rune Harald Gaarder stands out in the field of invention with his significant contributions to delivery devices. His patents not only reflect his technical prowess but also his commitment to improving medical delivery systems. As he continues to innovate, Gaarder's work promises to have a lasting impact on healthcare delivery.